Edge Medical Ventures (EdgeMed), which has an office in Detroit, has launched a new $70M MedTech fund that already has started to invest following an initial close.
Edge Medical Ventures, based in Or Yehuda, Israel (Tel Aviv District), intends to make several investments per year of $1-3 million per company, and also will reserve around $5-5 million for follow-on investments in each company.
Edge Medical Ventures is a fund investing in innovative medical technologies.
The founding partners of the new fund are veterans of the medical device industry, which have led the MEDX Xelerator incubator for the last seven years, include Shai Policker, CEO; Gal Atarot, CTO; and Noam Taichler, CFO. MEDX Xelerator is a leading Israeli Innovation Authority incubator which invested in and created 16 medical device companies.
Edge’s anchor investors include a major medical device corporation, Consensus Business Group (CBG), a leading investment group with a portfolio that includes pharma, biotech, med-tech, cleantech, real estate, and more, a family office based in the U.K., and other partners.
“During the past seven plus years at MEDX Xelerator, we came to appreciate the amazing talent and novel ideas emerging from the Israeli medtech echo system,” says Policker. “We also noticed the scarcity of capital. We believe this combination has created a unique opportunity.
“Our goal is to continue the proven venture creation collaboration with strategic partners as well as with leading hospitals worldwide, and to invest in those high-impact cutting-edge technology companies that have already undergone de-risking through pre-clinical and clinical research.”
Areas of interest include breakthrough medical device technologies in vascular interventions, urology, gastrointestinal, women’s health, home treatment, imaging, and minimal invasive surgery. The fund’s first investment already has been made and will be disclosed separately soon.
“I am glad to partner with the MEDX Xelerator team once again and invest in their new medtech fund,” says Vincent Tchenguiz, founder and chairman of CBG Investment Group. “I believe and know that Israeli health technologies hold a great opportunity and the ability to change reality in the near-term and especially in the future. Through the new Edge Medical Venture fund, we will be able to create an impact and promote medical companies to their next level of success.”
Edge operates a venture studio that identifies and develops groundbreaking medical devices and solutions in close collaboration with strategic partners, health care professionals, researchers, and industry experts around the world to accelerate the development and commercialization of novel technologies.
For more information, visit edgemed.vc.
, which has an office in Detroit, has launched a new $70M MedTech fund that already has started to invest following an initial close.){kind=link}